PAK1 and breast carcinoma: Whereas overexpression of PAK1 was identified as an independent prognostic marker of poor outcomes in ovarian cancer [151], it is a nuclear expression and phosphorylation (Ser305) in breast cancer cells that predict resistance to tamoxifen therapy.